Compare AU & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AU | A |
|---|---|---|
| Founded | 1944 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.9B | 35.8B |
| IPO Year | 2023 | 1999 |
| Metric | AU | A |
|---|---|---|
| Price | $84.54 | $130.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 15 |
| Target Price | $119.00 | ★ $161.47 |
| AVG Volume (30 Days) | ★ 3.0M | 1.6M |
| Earning Date | 05-08-2026 | 05-27-2026 |
| Dividend Yield | ★ 3.94% | 0.92% |
| EPS Growth | N/A | ★ 3.16 |
| EPS | N/A | ★ 2.27 |
| Revenue | N/A | ★ $4,472,000,000.00 |
| Revenue This Year | $38.71 | $8.45 |
| Revenue Next Year | $2.89 | $6.13 |
| P/E Ratio | ★ $23.93 | $58.63 |
| Revenue Growth | N/A | ★ 6.43 |
| 52 Week Low | $45.36 | $108.35 |
| 52 Week High | $129.14 | $160.27 |
| Indicator | AU | A |
|---|---|---|
| Relative Strength Index (RSI) | 45.85 | 53.94 |
| Support Level | $79.43 | $121.75 |
| Resistance Level | $88.90 | $139.19 |
| Average True Range (ATR) | 3.13 | 3.50 |
| MACD | -0.00 | -0.25 |
| Stochastic Oscillator | 33.16 | 52.06 |
Anglogold Ashanti PLC is an independent gold mining company. It has a diversified asset portfolio, including production from operations in eight countries (Argentina, Australia, Brazil, Egypt, Ghana, Guinea, the DRC, and Tanzania), supported by greenfield projects in the United States and Colombia. The company's main product is gold, which once mined, is processed into dore (unrefined gold bars) on site and then dispatched to precious metals refineries. Geographically, Anglogold generates maximum revenue from its operations in Africa (comprising operations at Kibali, Iduapriem, Obuasi, Siguiri, Geita, and Sukari mines), followed by Australia (including Sunrise Dam and Tropicana), and the Americas (comprising Cerro Vanguardia, AngloGold Ashanti Mineracao, and Serra Grande operations).
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.